Kevin Warsh Assumes Role as Federal Reserve Chair Under Trump Administration BJs Wholesale Club Plans Major Store Revamp as Consumer Spending Softens Roivant Shares Surge as Company Reports Swing to Profitability Professional Title Reddit Shares Slide Nearly 6 as Meta Launches Competing Forum App EU Parliament Approves US Tariff Deal Implementation Amid Trump Pressure Fed Dissenters Kashkari Logan Hammack Explain Opposition to Rate Cut Signal PLPC Q1 2026 Earnings EPS Surges 15 Above Estimates Amid Resilient Operations JTAI Q1 2026 Earnings WiderthanExpected Loss as JetAI Navigates EarlyStage Growth Under Armour Inc UAA Q1 2026 Earnings EPS Miss Clouds Start of Fiscal Year Despite Positive Revenue Trends MEDP Q1 2026 Earnings Strong EPS Beat Amid Solid Operational Performance MAXN Q4 2024 Earnings Massive EPS Beat as Loss Narrower Than Expected NewtekOne Senior Notes NEWTO Hold Steady at 26 as Yield Seeks Equilibrium FS Bancorp Inc FSBW Gains 157 as Stock Approaches Key Resistance Level VALE Faces Tepid Trading as Shares Hover Near Key Support Amid Mixed Commodity Signals Alamo Group ALG Climbs 171 as Shares Approach Key Resistance FULTP Q1 2026 Earnings EPS Beats Estimates Preferred Stock Declines Slightly AIRE Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid PreRevenue Phase Phibro Animal Health PAHC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Beat Mistras Group MG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction AMH Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Execution SLMBP Q1 2026 Earnings EPS Surges Past Estimates Preferred Stock Holds Steady Citi Initiates Coverage on Alnylam Pharmaceuticals with Buy Rating PSTL Q1 2026 Earnings Solid EPS Beat Amid Steady Operations Gladstone Commercial Preferred Stock GOODO Holds Steady Near 20 Amidst Stability ZKH Group Limited ZKH Gains 179 as Stock Approaches Key Resistance Level Saba Capital Income Opportunities Fund II SABA Edges Lower Amid Modest Trading Activity ENI SpA E Faces Pressure Testing Key Support After 18 Decline Design Therapeutics DSGN Edges Higher as Support Holds Above 1060 Nuveen Core Plus Impact Fund NPCT Holds Steady Near Key Support Levels CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223